Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1055806

	registered interest
	date	06/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the press release entitled, Dentists welcome official investigation into fines hitting vulnerable NHS patients, published on 30 January 2019 by the British Dental Association; whether he has plans to simplify the process for claiming free dental care to reduce the number of fines issued for ticking the wrong box on dental forms.
	tabling member constituency	Barnsley Central
	tabling member printed	Dan Jarvis
	uin	217586
	answer	answer is ministerial correction date of answer 12/02/2019 answer text <p>All National Health Service dental practices are required to display a poster showing patient charges and to offer patients a free leaflet which sets out in detail who is entitled to free NHS dental services. Information on exemptions and support for people who are on a low income can also be found at the following link:</p><p> </p><p><a href="http://www.nhs.uk/healthcosts" target="_blank">www.nhs.uk/healthcosts</a></p><p> </p><p>Eligibility checks are carried out on claims received for exemption from NHS Dental Patient Charges. Where eligibility cannot be verified, patients are asked to confirm their eligibility or to pay the relevant dental charge plus a penalty charge. Patients are, however, able to challenge penalty charges they believe are unjustified.</p><p> </p><p>The Department, NHS Business Services Authority and NHS England have recognised the concern that some patients may not be clear on whether they are exempt from charges and have been working to further improve the information available to patients around eligibility. This includes promoting an easy read patient information booklet, creating an online eligibility checker and developing a national awareness campaign.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217585 question first answered 12/02/2019 11:41:21 answering member 4067 label Biography information for Steve Brine previous answer version 101142 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	4243 label Biography information for Dan Jarvis

1055805

	registered interest
	date	06/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people are not issued with a penalty charge for ticking the wrong box on the claim form when claiming for free dental care.
	tabling member constituency	Barnsley Central
	tabling member printed	Dan Jarvis
	uin	217585
	answer	answer is ministerial correction date of answer 12/02/2019 answer text <p>All National Health Service dental practices are required to display a poster showing patient charges and to offer patients a free leaflet which sets out in detail who is entitled to free NHS dental services. Information on exemptions and support for people who are on a low income can also be found at the following link:</p><p> </p><p><a href="http://www.nhs.uk/healthcosts" target="_blank">www.nhs.uk/healthcosts</a></p><p> </p><p>Eligibility checks are carried out on claims received for exemption from NHS Dental Patient Charges. Where eligibility cannot be verified, patients are asked to confirm their eligibility or to pay the relevant dental charge plus a penalty charge. Patients are, however, able to challenge penalty charges they believe are unjustified.</p><p> </p><p>The Department, NHS Business Services Authority and NHS England have recognised the concern that some patients may not be clear on whether they are exempt from charges and have been working to further improve the information available to patients around eligibility. This includes promoting an easy read patient information booklet, creating an online eligibility checker and developing a national awareness campaign.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217586 question first answered 12/02/2019 11:41:21 answering member 4067 label Biography information for Steve Brine previous answer version 101141 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	4243 label Biography information for Dan Jarvis

1056832

	registered interest
	date	06/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Food: Nitrates
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy to require manufacturers to reduce the level of nitrates in processed foods; and if he will make a statement.
	tabling member constituency	East Yorkshire
	tabling member printed	Sir Greg Knight
	uin	218218
	answer	answer is ministerial correction date of answer 12/02/2019 answer text <p>Legislation on preservatives sets levels for nitrates in specific foods. These levels are based on extensive scientific evidence that ensures that such additives may be consumed safely over a lifetime and allows the achievement of their necessary technological function.</p><p> </p><p>The Food Standards Agency considers the current scientific evidence on nitrates is robust and shows nitrates continue to be highly effective in protecting consumers from dangerous pathogens like Clostridium botulinum which can present a serious risk to health.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/02/2019 15:47:38 answering member 4067 label Biography information for Steve Brine
	tabling member	1200 label Biography information for Sir Greg Knight

1056002

	registered interest
	date	06/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to provide community pharmacies with a multi-year funding settlement.
	tabling member constituency	St Austell and Newquay
	tabling member printed	Steve Double
	uin	217677
	answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The Department expects to begin negotiations on the Community Pharmacy Contractual Framework with the Pharmaceutical Services Negotiating Committee shortly. The length of any settlement will form part of those negotiations.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 11:59:14 answering member 4067 label Biography information for Steve Brine
	tabling member	4452 label Biography information for Steve Double

1055916

	registered interest
	date	06/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people have accessed cannabis-derived medicinal products under schedule 2 of the Misuse of Drugs Regulations 2001.
	tabling member constituency	Leigh
	tabling member printed	Jo Platt
	uin	217660
	answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:29:40 answering member 4067 label Biography information for Steve Brine
	tabling member	4673 label Biography information for Jo Platt

1055959

	registered interest
	date	06/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Biosimilar Medicines
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS document entitled Commissioning framework for biological medicines (including biosimilar medicines), what steps his Department plans to take to ensure that any decision to conduct a switch between biological medicines and biosimilar medicines is done with the approval of a physician and in consultation with patients.
	tabling member constituency	Bolton West
	tabling member printed	Chris Green
	uin	217623
	answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>NHS England has issued guidance around the commissioning of biological medicines and expects clinical commissioning groups (CCGs) to give due consideration to this guidance. The framework sets out the importance of developing local policies to support switching patients to biosimilars in line with best practice and where appropriate. The commissioning framework set out policy based on best practice but ultimately CCGs and hospital trusts are accountable for their own local decision making.</p><p><strong> </strong></p><p>All National Health Service organisations have a responsibility to encourage a shift in moving to shared decision making, and in ensuring that all patient consultations are done with a focus on shared decision making, and are happening at an individual healthcare professional/patient level.</p><p> </p><p>NHS England has also made clear that the decision to prescribe a biological medicine for an individual patient, whether an originator or biosimilar, or to change between the two, rests with the responsible prescriber in consultation with the patient, in line with the principles of shared decision making.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217619 217620 217621 question first answered 14/02/2019 17:32:01 answering member 4067 label Biography information for Steve Brine
	tabling member	4398 label Biography information for Chris Green

1055957

	registered interest
	date	06/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Biosimilar Medicines
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps NHS Improvement is taking to ensure that hospital trusts across the NHS are following shared decision-making principles and patient consent guidance within NHS England's Commissioning framework for biological medicines (including biosimilar medicines) when implementing biosimilar switching programmes.
	tabling member constituency	Bolton West
	tabling member printed	Chris Green
	uin	217622
	answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>NHS Improvement does not monitor use of shared decision making. It instead monitors uptake of the biosimilars as against the original – usually patented – medicines.</p><p> </p><p>It does, however, hold a joint role in supporting the National Health Service to use the best value biologic medicine which is part of a long standing programme of work connected to the NHS Biosimilar Medicines Programme Board, the NHS England Medicines Value Programme and the NHS Improvement Top 10 Medicines remit.</p><p> </p><p>The biosimilars medicines programme board is intended to ensure appropriate use of biosimilar medicines across the NHS in England. This includes shared decision making and patient consent and the board has produced guidance which sets out the importance of shared decision making which is fully endorsed by patient groups.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 12:01:49 answering member 4067 label Biography information for Steve Brine
	tabling member	4398 label Biography information for Chris Green

1055955

	registered interest
	date	06/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Biosimilar Medicines
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps NHS England is taking to ensure that that hospital trusts across the NHS are following shared decision-making principles and patient consent guidance within NHS England's Commissioning framework for biological medicines (including biosimilar medicines) when implementing biosimilar switching programmes.
	tabling member constituency	Bolton West
	tabling member printed	Chris Green
	uin	217621
	answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>NHS England has issued guidance around the commissioning of biological medicines and expects clinical commissioning groups (CCGs) to give due consideration to this guidance. The framework sets out the importance of developing local policies to support switching patients to biosimilars in line with best practice and where appropriate. The commissioning framework set out policy based on best practice but ultimately CCGs and hospital trusts are accountable for their own local decision making.</p><p><strong> </strong></p><p>All National Health Service organisations have a responsibility to encourage a shift in moving to shared decision making, and in ensuring that all patient consultations are done with a focus on shared decision making, and are happening at an individual healthcare professional/patient level.</p><p> </p><p>NHS England has also made clear that the decision to prescribe a biological medicine for an individual patient, whether an originator or biosimilar, or to change between the two, rests with the responsible prescriber in consultation with the patient, in line with the principles of shared decision making.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217619 217620 217623 question first answered 14/02/2019 17:32:00 answering member 4067 label Biography information for Steve Brine
	tabling member	4398 label Biography information for Chris Green

1055953

	registered interest
	date	06/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Biosimilar Medicines
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps are taken in cases where guidance within NHS England's Commissioning framework for biological medicines for biological medicines (including biosimilar medicines) is shown not to have been taken and patients are switched to a different medicine without their knowledge or consent.
	tabling member constituency	Bolton West
	tabling member printed	Chris Green
	uin	217620
	answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>NHS England has issued guidance around the commissioning of biological medicines and expects clinical commissioning groups (CCGs) to give due consideration to this guidance. The framework sets out the importance of developing local policies to support switching patients to biosimilars in line with best practice and where appropriate. The commissioning framework set out policy based on best practice but ultimately CCGs and hospital trusts are accountable for their own local decision making.</p><p><strong> </strong></p><p>All National Health Service organisations have a responsibility to encourage a shift in moving to shared decision making, and in ensuring that all patient consultations are done with a focus on shared decision making, and are happening at an individual healthcare professional/patient level.</p><p> </p><p>NHS England has also made clear that the decision to prescribe a biological medicine for an individual patient, whether an originator or biosimilar, or to change between the two, rests with the responsible prescriber in consultation with the patient, in line with the principles of shared decision making.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217619 217621 217623 question first answered 14/02/2019 17:32:00 answering member 4067 label Biography information for Steve Brine
	tabling member	4398 label Biography information for Chris Green

1055952

	registered interest
	date	06/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Biosimilar Medicines
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that hospital trusts adhere to (a) shared decision-making principles and (b) patient consent guidance within NHS England's Commissioning framework for biological medicines (including biosimilar medicines) when implementing bio-similar medicine switching programmes.
	tabling member constituency	Bolton West
	tabling member printed	Chris Green
	uin	217619
	answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>NHS England has issued guidance around the commissioning of biological medicines and expects clinical commissioning groups (CCGs) to give due consideration to this guidance. The framework sets out the importance of developing local policies to support switching patients to biosimilars in line with best practice and where appropriate. The commissioning framework set out policy based on best practice but ultimately CCGs and hospital trusts are accountable for their own local decision making.</p><p><strong> </strong></p><p>All National Health Service organisations have a responsibility to encourage a shift in moving to shared decision making, and in ensuring that all patient consultations are done with a focus on shared decision making, and are happening at an individual healthcare professional/patient level.</p><p> </p><p>NHS England has also made clear that the decision to prescribe a biological medicine for an individual patient, whether an originator or biosimilar, or to change between the two, rests with the responsible prescriber in consultation with the patient, in line with the principles of shared decision making.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217620 217621 217623 question first answered 14/02/2019 17:32:00 answering member 4067 label Biography information for Steve Brine
	tabling member	4398 label Biography information for Chris Green